Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 8, 1999, Pages 795-800

  Amin, Sanjiv B ^a   Sinkin, Robert A ^a   McDermott, Michael P ^a   Kendig, James W ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FATTY ACID; INSULIN; TRIACYLGLYCEROL;

ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DOSE RESPONSE; FATTY ACID BLOOD LEVEL; GESTATIONAL AGE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LUNG DYSPLASIA; METABOLIC DISORDER; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032774253     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.8.795     Document Type: Article

References (43)

1. American Academy of Pediatrics, Committee on Nutrition. Use of intravenous fat emulsions in pediatric patients. Pediatrics. 1981;68:738-743.
2. Shennan AT, Bryan MH, Angel A. The effect of gestational age on intralipid tolerance in newborn infants. J Pediatr. 1977;91:134-137.
3. Economides DL, Nicolaides KH, Campbell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med. 1991;19:97-105.
4. Andrew G, Chan G, Schiff D. Lipid metabolism in the neonate, I: the effects of intralipid infusion on plasma triglyceride and free fatty acid concentrations in the neonate. J Pediatr. 1976;88:273-278.
5. Haumont D, Deckelbaum RJ, Richelle M, et al. Plasma lipid and plasma lipoprotein concentration in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion. J Pediatr. 1989;115:787-793.
6. Park W, Paust H, Schroder H. Lipid infusion in premature infants suffering from sepsis. JPEN J Parenter Enteral Nutr. 1984;8:290-292.
7. Stahl GE, Spear ML, Hamosh M. Intravenous administration of lipid emulsions to premature infants. Clin Perinatol. 1986;13:150-152.
8. Uhlinger DJ, Burnham DM, Mullins RE Jr, et al. Functional differences in human neutrophils isolated pre- and post-prandially. FEBS Lett. 1991;286:28-32.
9. English D, Roloff JS, Lukens JN, Parker P, Greene HL, Ghishan FK. Intravenous lipid emulsion and human neutrophil function. J Pediatr. 1981;99:913-916.
10. Thiessen H, Jacobsen J, Brodersen R. Displacement of albumin-bound bilirubin by fatty acids. Acta Paediatr. 1972;61:285-288.
11. Andrew G, Chan G, Schiff D. Lipid metabolism in the neonate, II: the effect of intralipid on bilirubin binding in vitro and in vivo. J Pediatr. 1976;88:279-284.
12. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respiratory-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985;75:106-111.
13. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994;36:122-128.
14. Davis JM, Rosenfield W. Chronic lung disease. In: Avery GB, Fletcher MA, MacDonald MG, eds. Pathophysiology and Management of the Newborn. Philadelphia, Pa: JB Lippincott; 1994:453-477.
15. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone treatment in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990;117:273-282.
16. Van Goudoever JB, Wattimena JD, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr. 1994;124:112-118.
17. Amatruda JM, Danahy SA, Chang CL. The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. Biochem J. 1983; 212:135-141.
18. Mangiapane EH, Brindley DN. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J. 1986;233:151-160.
19. Bartlett SM, Gibbons GF. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes: a biphasic effect of insulin. Biochem J. 1988;249:37-43.
20. Brindley DN, Cooling J, Burditt SL, Pritchard PH, Pawson S, Sturton RG. The involvement of glucocorticoids in regulating the activity of phosphatide phosphohydralase and the synthesis of triacylglycerols in the liver: effects of feeding rats with glucose, sorbitol, fructose, glycerol and ethanol. Biochem J. 1979;180: 195-199.
21. Cole TG, Wilcox HG, Heimberg M. Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism. J Lipid Res. 1982;23:81-91.
22. Diamant S, Shafrir E. Modulation of the activity of insulin-dependent enzymes of lipogenesis by glucocorticoids. Eur J Biochem. 1975;53:541-546.
23. Jennings RJ, Lawson N, Fears R, Brindley DN. Stimulation of the activities of phosphatidate phosphohydrolase and tyrosine aminotransferase in rat hepatocytes by glucocorticoids. FEBS Lett. 1981;133:119-122.
24. Reaven EP, Kolterman OG, Reaven GM. Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles. J Lipid Res. 1974;15:74-83.
25. Byrne CD, Brindle NP, Wang TW, Hales CN. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep 62 cells. Biochem J. 1991;280:99-104.
26. Wang SR, Pessah M, Infante J, Catala D, Salvat C, Infante R. Lipid and lipoprotein metabolism in Hep G2 cells. Biochim Biophys Acta. 1988;961:351-363.
27. Cascales C, Mangiapane EH, Brindley DN. Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem J. 1984;219:911-916.
28. Perley M, Kipnis DM. Effect of glucocorticoids on plasma insulin. N Engl J Med. 1966;274:1237-1241.
29. Ashmore J. The effects of glucocorticoids on insulin action. Diabetes. 1964;13: 349-353.
30. Witters LA, Moriarity D, Martin DB. Regulation of hepatic acetyl coenzyme A carboxylase by insulin and glucagon. J Biol Chem. 1979;254:6644-6649.
31. Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta. 1994;1215:9-32.
32. Rovamo L, Nikkila EA, Taskinen MR, Raivio KO. Postheparin plasma lipoprotein and hepatic lipase in preterm neonates. Pediatr Res. 1984;18:1104-1107.
33. Putet G. Lipids as an energy source for the premature and full term neonate. In: Polin PA, Fox WW, eds. Fetal and Neonatal Physiology. Philadelphia, Pa: WB Saunders Co: 1992:326-329.
34. Dhanireddy R, Hamosh M, Sivasubramanian KN, Chowdhry P, Scanlon JW, Hamosh P. Postheparin lipolytic activity and intralipid clearance in very low-birth-weight infants. J Pediatr. 1981;98:617-622.
35. American Academy of Pediatrics. Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics. 1985;75:976-986.
36. Brans YW, Andrew DS, Carrillo DW, Dutton EP, Menchaca EM, Puleo-Scheppke BA. Tolerance of fat emulsion in very-low-birth-weight neonates. AJDC. 1988; 142:145-152.
37. Printer A. Metabolic changes in newborn infants following surgical operations, I: blood levels of glucose, plasma free fatty acids, alpha-amino nitrogen, plasma amino acid ratio and urea nitrogen. Acta Paediatr Acad Sci Hung. 1975;16:171-180.
38. Di Toro R, Ansanelli V, Lupi L, Tiberio P. Plasma lipid changes induced by epinephrine: a study carried out in premature babies fed with formulas of different lipid composition. J Pediatr. 1969;74:709-716.
39. Keyes WG, Wilcox HG, Heimburg M. Formation of the very low density lipoprotein and metabolism of [1-14C]-oleate by perfused livers from rats treated with triiodothyronine or propylthiouracil. Metabolism. 1981;30:135-146.
40. Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev. 1988;4:639-652.
41. Moir AM, Zammit VA. Effects of insulin treatment of diabetic rats on hepatic partitioning of fatty acids between oxidation and esterification, phospholipid and acylglycerol synthesis, and on the fractional rate of secretion of triacylglycerol in vivo. Biochem J. 1994;304:177-182.
42. Laker ME, Mayes PA. Investigations into the direct effects of insulin on hepatic ketogenesis, lipoprotein secretion and pyruvate dehydrogenase activity. Biochim Biophys Acta. 1984;795:427-430.
43. Bagdade JD, Yee E, Albers J, Pykalisto OJ. Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism. 1976;25:533-542.